Filing Details

Accession Number:
0001410442-24-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-03 18:05:36
Reporting Period:
2024-09-03
Accepted Time:
2024-09-03 18:05:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883984 Icu Medical Inc ICUI Surgical & Medical Instruments & Apparatus (3841) 330022692
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1410442 Vivek Jain 951 Calle Amanecer
San Clemente CA 92673
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-03 3,755 $88.76 108,348 No 4 M Direct
Common Stock Disposition 2024-09-03 3,755 $162.69 104,593 No 4 S Direct
Common Stock Acquisiton 2024-09-03 4,440 $88.76 109,033 No 4 M Direct
Common Stock Disposition 2024-09-03 4,440 $163.59 104,593 No 4 S Direct
Common Stock Acquisiton 2024-09-03 3,805 $88.76 108,398 No 4 M Direct
Common Stock Disposition 2024-09-03 3,805 $164.07 104,593 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2024-09-03 3,755 $88.76 3,755 $88.76
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2024-09-03 4,440 $88.76 4,440 $88.76
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2024-09-03 3,805 $88.76 3,805 $88.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,618 2018-02-11 2025-02-11 No 4 M Direct
41,178 2018-02-11 2025-02-11 No 4 M Direct
37,373 2018-02-11 2025-02-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 88,698 Indirect by Trust
Footnotes
  1. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.98 to $162.94, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.99 to $163.96, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to $164.5, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.